semaglutide
Cost Surge as Semaglutide Leaves Bulk List?
The FDA’s decision to remove semaglutide from the 503B bulk list will increase acquisition costs for pharmacies and push patient copays higher. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Semaglutide’s